Rep. Elijah Cummings (D-MD) continued his scrutiny of Valeant Pharmaceuticals -- which has been criticized for its drug pricing policies -- by requesting CEO Michael Pearson provide transcribed interviews from the company's employees as new allegations emerged that it was Valeant employees who launched Philidor, a specialty pharmacy that Valeant allegedly used to mask its price increases and circumvent the traditional insurance reimbursement process. Cummings' Nov. 16 letter to the CEO states that “troubling new allegations suggest that a group...